MoonLake Immunotherapeutics
MLTX
#3933
Rank
NZ$4.21 B
Marketcap
$66.60
Share price
-4.48%
Change (1 day)
-12.59%
Change (1 year)

EPS for MoonLake Immunotherapeutics (MLTX)

EPS in 2023 (TTM): -$1.93

According to MoonLake Immunotherapeutics's latest financial reports the company's current EPS (TTM) is -$2.05. In 2022 the company made an earnings per share (EPS) of -$2.59.

EPS history for MoonLake Immunotherapeutics from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.93-25.51%
2022-$2.59